November 2013 FDA Recall Ketoconazole by Fougera Pharmaceuticals Inc.
D-1044-2014 - Failed Impurities/Degradation Specifications

This Class III drug recall was voluntarily initiated by Fougera Pharmaceuticals Inc. on November 18, 2013 for the product Ketoconazole. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1044-2014

Reason for Recall
Failed Impurities/Degradation Specifications: Out-of-Specification degradant results.
Initiated
11-18-2013
Reported
02-05-2014
Quantity
31,122 tubes

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Fougera Pharmaceuticals Inc.
Nationwide and Puerto Rico
KETOCONAZOLE CREAM, 2%, 30 gram tube, Rx only, E. FOUGERA & CO., A division of Fougera Pharmaceuticals Inc., Melville, New York 11747, NDC 0168-0099-30, UPC 3 0168-0099-30 9.

Batch or Lot Expiration Information

Lot# : 495P, Exp 07/14